Gain Therapeutics, Inc.
GANX
$3.32
$0.268.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.91% | -60.47% | -28.36% | -38.16% | -1.50% |
| Total Receivables | 111.02% | 351.53% | 255.92% | 215.66% | 266.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.10% | -7.06% | 25.38% | -39.20% | 45.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -23.46% | -49.80% | -19.56% | -34.74% | 3.77% |
|
|
|||||
| Total Current Assets | -23.46% | -49.80% | -19.56% | -34.74% | 3.77% |
| Net Property, Plant & Equipment | -32.70% | -26.77% | -43.32% | -44.75% | -35.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -26.68% | -19.10% | -25.35% | -30.56% | -17.39% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.33% | 41.70% | 31.98% | 22.93% | 37.94% |
| Total Assets | -23.63% | -48.77% | -20.26% | -34.85% | 1.90% |
|
|
|||||
| Total Accounts Payable | 43.58% | 32.55% | 53.10% | -28.26% | -20.22% |
| Total Accrued Expenses | -7.12% | -36.41% | 3.72% | 14.77% | -5.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -18.71% | -11.92% | -16.99% | -22.21% | -12.72% |
| Total Finance Division Other Current Liabilities | -92.10% | -93.69% | -76.17% | -76.88% | -48.76% |
| Total Other Current Liabilities | -92.10% | -93.69% | -76.17% | -76.88% | -48.76% |
| Total Current Liabilities | -9.23% | -20.33% | 0.49% | -20.98% | -20.28% |
|
|
|||||
| Total Current Liabilities | -9.23% | -20.33% | 0.49% | -20.98% | -20.28% |
| Long-Term Debt | -20.55% | -13.32% | -20.74% | -26.90% | -13.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -32.43% | -30.83% | -82.75% | -76.69% | -63.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.65% | 37.99% | 31.98% | 22.10% | 27.62% |
| Total Liabilities | -7.22% | -17.18% | -1.53% | -20.67% | -19.37% |
|
|
|||||
| Common Stock & APIC | 18.67% | 11.73% | 24.80% | 21.43% | 36.01% |
| Retained Earnings | -25.05% | -25.49% | -32.30% | -33.58% | -38.11% |
| Treasury Stock & Other | 131.96% | 4,572.80% | -647.49% | -200.12% | 167.70% |
| Total Common Equity | -33.67% | -68.64% | -33.12% | -41.65% | 21.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.67% | -68.64% | -33.12% | -41.65% | 21.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.67% | -68.64% | -33.12% | -41.65% | 21.53% |
|
|
|||||